61 results
424B5
YTEN
Yield10 Bioscience Inc
2 Feb 21
Prospectus supplement for primary offering
4:36pm
to complete the regulatory process for or commercialize such products.
If we lose key personnel or are unable to attract and retain necessary talent … on our business and operations.
If we lose key personnel or are unable to attract and retain necessary talent, we may be unable to develop
424B5
YTEN
Yield10 Bioscience Inc
29 Jan 21
Prospectus supplement for primary offering
4:48pm
key personnel or are unable to attract and retain necessary talent, we may be unable to develop or commercialize our products under development … talent, we may be unable to develop or commercialize our products under development.
We are highly dependent on our key technical and scientific
424B4
zgobm9h
19 Oct 20
Prospectus supplement with pricing info
4:51pm
424B5
0wk3tv3n0awbingbqj73
25 Aug 20
Prospectus supplement for primary offering
4:08pm
424B5
b8l6gx00vo9q qii
21 Aug 20
Prospectus supplement for primary offering
5:22pm
424B4
ald5ce42z6c9oonukc
3 Apr 20
Prospectus supplement with pricing info
10:36am
424B4
kwlvc5e
18 Nov 19
Prospectus supplement with pricing info
12:00am
424B5
cyevi8e9tzi0pr6
18 Mar 19
Prospectus supplement for primary offering
12:00am